Soru

Zorluk: OrtaInfectious Diseases

A 4141-year-old man is evaluated in the hospital on the third day of his admission for community-acquired pneumonia. He initially presented with a two-day history of high fever, productive cough, and right-sided pleuritic chest pain. On admission, his temperature was 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure was 118/74 mm Hg118/74\text{ mm Hg}, pulse was 110/min110\text{/min}, and respirations were 24/min24\text{/min}. Chest radiography showed a right lower lobe consolidation. He was subsequently started on empiric intravenous levofloxacin.

Today, the patient reports feeling significantly better. He has been afebrile for the past 24 hours24\text{ hours}, and his cough has improved. Current vital signs are temperature 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure 122/78 mm Hg122/78\text{ mm Hg}, pulse 82/min82\text{/min}, and respirations 16/min16\text{/min}. He is tolerating a regular diet.

Blood cultures drawn on admission are now positive for Streptococcus pneumoniae. Susceptibility testing of the isolate demonstrates the following:

AntimicrobialInterpretation
PenicillinSusceptible
AmoxicillinSusceptible
CeftriaxoneSusceptible
LevofloxacinSusceptible
AzithromycinResistant

Which of the following is the most appropriate next step in pharmacotherapy?

  1. A
    Continue intravenous levofloxacin for a total of 5 days
  2. B
    Transition to oral amoxicillin-clavulanate
  3. Transition to oral amoxicillinCevap
  4. D
    Transition to oral cefdinir
  5. E
    Transition to oral levofloxacin

Cevap

Transition to oral amoxicillin
This patient has community-acquired pneumonia and has demonstrated significant clinical improvement, making him an excellent candidate for intravenous-to-oral antibiotic transition. Blood cultures grew Streptococcus pneumoniae that is susceptible to penicillin and amoxicillin. According to core principles of antibiotic stewardship, therapy should be narrowed from empiric broad-spectrum coverage (levofloxacin) to the most targeted effective agent once susceptibility data are available. Oral amoxicillin is the ideal narrow-spectrum agent for treating penicillin-susceptible S. pneumoniae.

Adım Adım Çözüm

1
Assess the patient's clinical trajectory and criteria for IV to PO transition.
The patient is hemodynamically stable, afebrile for 24 hours, and tolerating an oral diet.
Establishing clinical stability confirms that the patient is ready to step down from intravenous to oral antibiotics.
2
Analyze the culture and susceptibility results.
The pathogen is Streptococcus pneumoniae, which is susceptible to penicillin and amoxicillin.
Identifying the specific organism and its susceptibility profile allows for targeted, pathogen-specific therapy rather than empiric broad-spectrum coverage.
3
Select the most appropriate antibiotic according to stewardship principles.
Oral amoxicillin is selected over oral levofloxacin, cefdinir, or amoxicillin-clavulanate.
Amoxicillin provides the most targeted, narrow-spectrum coverage for penicillin-susceptible S. pneumoniae, minimizing collateral damage to the patient's microbiome.

Anahtar Kavram

In patients hospitalized for community-acquired pneumonia, empiric broad-spectrum antibiotics should be de-escalated to the narrowest effective oral agent once clinical stability is achieved and culture/susceptibility data are available.
Bu soruyu puanla